Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gasser

Showing results (131-140 of 144) with videos related to

Pageof 15
Sort By:
Archives of Internal Medicine|September 26, 2007
Visceral leishmaniasis: clinical observations in 4 US army soldiers deployed to Afghanistan or Iraq, 2002-2004Otha Myles, Glenn W Wortmann, James F Cummings, et al.
Vaccine|April 7, 2024
A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adultsJ F Cummings, M E Polhemus, K E Kester, et al.
Gastroenterology|April 10, 2017
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a StudyBruce E Sands, Jingjing Chen, Brian G Feagan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experienceN E Aronson, G W Wortmann, S C Johnson, et al.
Cell Chemical Biology|November 21, 2023
Genetic retargeting of E3 ligases to enhance CAR T cell therapyIsabel C Lane, Gabriele Kembuan, Jeannie Carreiro, et al.
Journal of Clinical Microbiology|July 28, 2001
Malaria rapid diagnostic devices: performance characteristics of the ParaSight F device determined in a multisite field studyJ R Forney, A J Magill, C Wongsrichanalai, et al.
Vaccine|June 19, 2007
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adultsKent E Kester, Denise A McKinney, Nadia Tornieporth, et al.
Science Translational Medicine|January 7, 2021
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Irene Scarfò, Rebecca C Larson, et al.
Nature|November 19, 2020
Small-molecule-induced polymerization triggers degradation of BCL6Mikołaj Słabicki, Hojong Yoon, Jonas Koeppel, et al.
Blood|May 3, 2019
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogsAdam S Sperling, Michael Burgess, Hasmik Keshishian, et al.
Pageof 15

Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
Archives of Internal Medicine|September 26, 2007
Visceral leishmaniasis: clinical observations in 4 US army soldiers deployed to Afghanistan or Iraq, 2002-2004Otha Myles, Glenn W Wortmann, James F Cummings, et al.
Vaccine|April 7, 2024
A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adultsJ F Cummings, M E Polhemus, K E Kester, et al.
Gastroenterology|April 10, 2017
Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a StudyBruce E Sands, Jingjing Chen, Brian G Feagan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experienceN E Aronson, G W Wortmann, S C Johnson, et al.
Cell Chemical Biology|November 21, 2023
Genetic retargeting of E3 ligases to enhance CAR T cell therapyIsabel C Lane, Gabriele Kembuan, Jeannie Carreiro, et al.
Journal of Clinical Microbiology|July 28, 2001
Malaria rapid diagnostic devices: performance characteristics of the ParaSight F device determined in a multisite field studyJ R Forney, A J Magill, C Wongsrichanalai, et al.
Vaccine|June 19, 2007
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adultsKent E Kester, Denise A McKinney, Nadia Tornieporth, et al.
Science Translational Medicine|January 7, 2021
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomideMax Jan, Irene Scarfò, Rebecca C Larson, et al.
Nature|November 19, 2020
Small-molecule-induced polymerization triggers degradation of BCL6Mikołaj Słabicki, Hojong Yoon, Jonas Koeppel, et al.
Blood|May 3, 2019
Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogsAdam S Sperling, Michael Burgess, Hasmik Keshishian, et al.
Pageof 15